1601.5000 8.00 (0.50%)
NSE Jun 12, 2026 15:31 PM
Volume: 192.4K
 

1601.50
0.50%
Emkay
DLPL posted a robust quarter, with revenue growing 11% YoY on the back of
sample volume increasing 9% YoY and Swasthfit contributing 24% to the
topline.
Dr. Lal Pathlabs Ltd. has an average target of 1658.50 from 2 brokers.
More from Dr. Lal Pathlabs Ltd.
Recommended